Javier Schlatter Navarro *

Autor invitado por SIIC

El trabajo contribuye a conocer algunos aspectos fisiopatológicos de tipo inmunitario que podrían ser específicos de la depresión melancólica

CARACTERISTICAS LINFOCITARIAS DIFERENCIALES DE LA DEPRESION MELANCOLICA

Se compararon el fenotipo linfocitario y la producción de linfoquinas en un grupo de pacientes con depresión no melancólica y otro con depresión melancólica y se compararon con un grupo de controles sanos. Encontramos mayor número de linfocitos CD4+ – que desaparece con la remisión– en los pacientes melancólicos respecto de los sanos. También hayamos un aumento de IL-2 ( que se normaliza tras la remisión) en todos los pacientes deprimidos en relación con los controles sanos.

*Javier Schlatter Navarro
describe para SIIC los aspectos relevantes de su trabajo
LYMPHOCYTE SUBSETS AND LYMPHOKINE PRODUCTION IN PATIENTS WITH MELANCHOLIC VERSUS NONMELANCHOLIC DEPRESSION
Institución principal de la investigación
*Departamento de Psiquiatría y Psicología Médica. Clínica Universitaria de Navarra, Pamplona, España, Pamplona, España
Imprimir nota

Referencias bibliográficas
Anisman H, Ravindran AV, Griffiths J & Merali Z. (1999). Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Molecular Psychiatry 4, 182-188.American Psychiatric Association. Diagnostic and Statistical Manual for Psychiatric Diagnoses, Fourth Edition, American Psychiatric Press, Washington DC, 2000.Bryant J, Day R, Whiteside TL & Herberman RB. (1992). Calculation of lytic units for the expression of cell-mediated cytotoxicity. Journal of Immunological Methods. 146, 91-106. Castilla-Cortazar I, Castilla A & Gurpegui M. (1998). Opioid peptides and immunodysfunction in patients with major depression and anxiety disorders. Journal of Physiology and Biochemistry 54, 203-215.Chu L, Tian S, Chen H & Zhou Z. Study on natural killer cell subset and activity in patients with depression. (2002). Zhonghua-yi-xue-za-zhi 82, 830-831.Evans DL, Folds LD & Petitto JM. (1992). Circulating natural killer cell phenotypes in males and females with major depression: relation to cytotoxic activity and severity of depression. Archives of General Psychiatry 43, 111-119.Guy W. (1976). ECDEU assessment manual for psychopharmacology. National Insitute for Mental Health, Psychopharmacology Research Branch.Bethesda MD, Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM. (1995). Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-a in human peripheral blood. Cytokine 8, 815-822.Hamilton M. (1959). The assessment of anxiety states by rating. British Journal Medical Psychology 32, 50-55.Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal Society Clinical Psychology 6, 278-296.Herbert TB & Cohen S. (1993). Depression and immunity -A meta-analytic review. Psychological Bulletin 113, 472-486.Hickie I, Hickie C, Lloyd A, Silove D & Wakefield D. (1993). Impaired in vivo immune responses in patients with melancholia. British Journal of Psychiatry 162, 651-7.Irwin M. (2001). Depression and immunity. In: Psychoneuroimmunology (ed. R Ader, DL Felten and N Cohen), pp. 383-398 (Vol. 2). Academic Press: San Diego.Irwin M. (1999). Immune correlates of depression. Advances in Experimental Medicine and Biology 461, 1-24.Irwin M, Lacher U & Caldwell C. (1992). Depression and reduced natural killer citotoxicity: A longitudinal study of depressed patients and control subjects. Psychological Medicine 22, 1045-1050.Kanba S, Manki H, Shintani F, Ohno Y, Yagi G & Asai M. (1998). Aberrant interleukin-2 receptor-mediated blastoformation of peripheral blood lymphocytes in a severe major depressive episode. Psychological Medicine 28, 481-484.Kubera M, Van Bockstaele D & Maes M. (1999). Leukocyte subsets in treatment-resistant major depression. Polish Journal of Pharmacology 51, 547-549.Maes M, Lambrechts J, Suy E, Vandeervorst C & Bosmans E. (1994). Absolute number and percentage of circulating natural killer, non-MHC-restricted T-cytotoxic, and phagocytic cells in unipolar depression. Neuropsychobiology 29, 157-163.Maes M, Bosmans E, Suy E, Minner B & Raus J. (1989). Immune cell parameters in severely patients: negative findings, Journal of Affective Disorders 17, 121-128.Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, De Jonckheere C, Minner B & Raus J. (1992a). Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychological Medicine 22, 45-53.Maes M, Smith R & Scharpe S. (1995). The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20, 111-116.Maes M, Van Planken M, Stevens WJ, Peeters D, DeClerck LS, Bridts CH, Schotte C & Cosyns P. (1992b). Leukocytosis, Monocytosis and Neutrophilia: Hallmarks of severe depression. Journal of Psychiatry Research 26, 125-134.Maes M, Verkerk R, Vandoolaeghe E, VanHunsel F, Neels H, Wauters A, Demedts P & Scharpé S. (1997). Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. European Archives of Psychiatry and Clinical Neuroscience 247, 154-161.Mosmann TR & Coffman RL. (1989). Th1 and Th2 cells: different patterns of lymphokine secretion lead to deifferent functional properties. Annual Revue of Immunology 7, 145-173.Natelson BH, Denny T, Zhou XD, LaManca JJ, Ottenweller JE & Tiersky L. (1999). Is depression associated with immune activation. Journal of Affective Disorders 53, 179-184.Ravindran AV, Griffiths J, Merali Z & Anisman H. (1998). Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features. Psychosomatic Medicine 60, 283-289.Ravindran AV, Griffiths J, Merali Z & Anisman H. (1996). Primary dysthymia: A study of several psychosocial, endocrine and immune correlates. Journal of Affective Disorders 40, 73-84.Ravindran AV, Griffiths J, Merali Z & Anisman H. (1995). Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment. Psychosomatic Medicine 57, 555-563.Schleifer SJ, Bartlett JA, Keller SE, Eckholdt HM, Shiftlett SC & Delaney BR. (2002). Immunity in adolescents with major depression. Journal of the American Academy of Child and Adolescent Psychiatry 41, 1054-1060.Schleifer SJ, Keller SE & Bartlett JA. (1999). Depression and immunity: clinical factors and therapeutic course. Psychiatry Research 85, 63-69.Schleifer SJ, Keller SE, Bartlett JA, Eckholdt HM & Delaney BR. (1996). Immunity in young adults with major depression. American Journal of Psychiatry 153, 472-482.Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A & Kirchner H. (1996). Acta Psychiatrica Scandinavica 94, 198-204.Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A & Kirchner H. (1995). Cytokine production and serum proteins in depression. Scandinavica Journal of Immunology 41, 534-538.Stein M, Miller AH & Trestman RL. (1991). Depression, the immune system, and health and illness. Archives of General Psychiatry 48, 171-177.Weisse CS. (1992). Depression and immunocompetence: A review of the literature. Psychological Bulletin 111, 475-489.Weizman R, Laor N, Podliszevski E, Notti I, Djaldetti M & Bessler H. (1994). Cytokine production in major depressed patients before and after clomipramine treatment. Biological Psychiatry 35, 42-47.Whiteside TL, Bryant J, Day R & Herberman RB. (1990). Natural Killer citotoxicity in the diagnosis of immune function. Journal of Clinical Laboratory Analysis 4, 102-114.Zaharia MD, Ravindran AV, Griffiths J, Merali Z & Anisman H. (2000). Lymphocyte proliferation among major depressive and dysthimic patients with typical or atypical features. Journal of Affective Disorders 58, 1-10.

Otros artículos de Javier Schlatter Navarro

Schlatter J, Ortuño F, Cervera-Enguix S. Differences in interleukin' patterns between dysthymia and major depression. European Psychiatry 2001; 16:317-9.Schlatter J, Ortuño F, Cervera-Enguix S. Monocytic parameters in patients with dysthymia versus major depression. Journal of Affective Disorders 2004; 78:243-7.Schlatter J, Soutullo C, Cervera-Enguix S. First break of mania associated with topiramate treatment. Journal of Clinical Psychopharmacology 2001; 21:464-6.Cervera-Enguix S, Schlatter J. Aspectos etiopatogénicos actuales en la fobia social. Psiquiatría Biológica 2003; 10 (2):43-52.

Para comunicarse con Javier Schlatter Navarro mencionar a SIIC como referencia:
schlatter@unav.es

---

Acerca del trabajo completo

CARACTERISTICAS LINFOCITARIAS DIFERENCIALES DE LA DEPRESION MELANCOLICA

Título original en castellano
SUBTIPOS LINFOCITARIOS Y PRODUCCION DE LINFOQUINAS EN PACIENTES CON DEPRESION MELANCOLICA FRENTE A NO MELANCOLICA

Autor
Javier Schlatter Navarro¹
1 Médico, Departamento Psiquiatría, Clínica Universitaria, Universidad de Navarra, Colaborador Clínico

Acceso a la fuente original
Psychiatry Research
http://www.elsevier.com/locate/psychres